Literature DB >> 12186545

A conserved cis peptide bond is necessary for the activity of Bowman-Birk inhibitor protein.

Arnd B E Brauer1, Gonzalo J Domingo, Robert M Cooke, Stephen J Matthews, Robin J Leatherbarrow.   

Abstract

The Bowman-Birk inhibitor (BBI) family of protease inhibitors has an inhibitory region comprising a disulfide-linked nine-residue loop that adopts the characteristic canonical motif found in many serine protease inhibitors. A unique feature of the BBI loop is the presence of a cis peptide bond at the edge of the inhibitory loop. BBI-related protein fragments that encapsulate this loop retain the structure and inhibitory activity of the parent protein. The most common BBI loop sequence has a proline-proline element with a cis-trans geometry at P3'-P4'. We have examined this element by analysis of the inhibitory activity and structure for a series of synthetic fragments where each of these proline residues has been systematically replaced with alanine. The results show that only when a proline is present at P3' are potent inhibition and a cis peptide bond at that position in the solution structure observed, suggesting that this conformation is required for biological activity. Though a P4' proline is not essential for activity, it effectively stabilizes the cis conformation at P3' by suppressing alternative conformations. This is most evident from the Pro-Ala variant, which comprises a 1:1 mixture of slowly exchanging and structurally different cis and trans isomers. Monitoring the action of trypsin on this mixture by NMR shows that this protease interacts selectively with the cis P3' structure, providing direct evidence for the link between activity and the nativelike structure of the cis isomer. This is, to the best of our knowledge, the first example where cis isomer selectivity can be demonstrated for a proteinase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186545     DOI: 10.1021/bi026050t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Cis-trans peptide variations in structurally similar proteins.

Authors:  Agnel Praveen Joseph; Narayanaswamy Srinivasan; Alexandre G de Brevern
Journal:  Amino Acids       Date:  2012-01-08       Impact factor: 3.520

2.  In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclization.

Authors:  U Malik; O N Silva; I C M Fensterseifer; L Y Chan; R J Clark; O L Franco; N L Daly; D J Craik
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

3.  Evidence for Ancient Origins of Bowman-Birk Inhibitors from Selaginella moellendorffii.

Authors:  Amy M James; Achala S Jayasena; Jingjing Zhang; Oliver Berkowitz; David Secco; Gavin J Knott; James Whelan; Charles S Bond; Joshua S Mylne
Journal:  Plant Cell       Date:  2017-03-14       Impact factor: 11.277

4.  Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approach.

Authors:  Anna Łegowska; Dawid Debowski; Adam Lesner; Magdalena Wysocka; Krzysztof Rolka
Journal:  Mol Divers       Date:  2009-04-09       Impact factor: 2.943

5.  Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.

Authors:  Rushikesh Sable; Thomas Durek; Veena Taneja; David J Craik; Sandeep Pallerla; Ted Gauthier; Seetharama Jois
Journal:  ACS Chem Biol       Date:  2016-07-01       Impact factor: 5.100

6.  Absolute side-chain structure at position 13 is required for the inhibitory activity of bromein.

Authors:  Yoriko Sawano; Ken-ichi Hatano; Takuya Miyakawa; Masaru Tanokura
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

7.  De novo molecular modeling and biophysical characterization of Manduca sexta eclosion hormone.

Authors:  J Joe Hull; Kathrin S Copley; Kathleen M Schegg; David R Quilici; David A Schooley; William H Welch
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

8.  SUMO protease SENP1 induces isomerization of the scissile peptide bond.

Authors:  Linnan Shen; Michael H Tatham; Changjiang Dong; Anna Zagórska; James H Naismith; Ronald T Hay
Journal:  Nat Struct Mol Biol       Date:  2006-11-12       Impact factor: 15.369

9.  A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.

Authors:  Sitanshu S Singh; George Mattheolabakis; Xin Gu; Sita Withers; Achyut Dahal; Seetharama Jois
Journal:  Eur J Med Chem       Date:  2021-02-23       Impact factor: 6.514

10.  Solution structure of a novel C2-symmetrical bifunctional bicyclic inhibitor based on SFTI-1.

Authors:  Agnès M Jaulent; Arnd B E Brauer; Stephen J Matthews; Robin J Leatherbarrow
Journal:  J Biomol NMR       Date:  2005-09       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.